Back to search

Germany· DE-A57-bfa04f9b8ad030bb

Ferro Sanol Duodenal

A medicinal product containing ferrous (ii) glycine sulfate complex, registered in Germany by Teofarma S.R.L..

Checked against EMA Article 57 (European Union) on

Informational only — not a medical device.

SOURCE REGISTER · DEEMA Article 57 (European Union)normalisedFerro Sanol DuodenalATC—REGISTER NO.DE-A57-bfa04f9b8ad030…PACKS LISTED0CHECKEDSeptember 30, 2026

The record

At a glance

EMA Article 57 (European Union)
Active substance
Ferrous (Ii) Glycine Sulfate Complex
Manufacturer
Teofarma S.R.L.
Country
Germany (DE)
ATC code
—
Reimbursed
Not published by this register
Source register
EMA Article 57 (European Union)
Last checked
September 30, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Ferrous (ii) glycine sulfate complex in 2 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ferrous (ii) glycine sulfate complex products

Authorised across Europe · EMA

The same active substance is authorised in 8 EEA countries. Names it is sold under:

  • Denmark · Niferex
  • Spain · Ferbisol, Ferro Sanol
  • Finland · Spartofer
  • Greece · Ferro Duodenal Sanol
  • Italy · Niferex
  • Norway · Niferex
  • Poland · Obsidan
  • Sweden · Niferex

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e48b210b-1b49-45e3-a356-37ba2af30d77
GET /v1/drugs/e48b210b-1b49-45e3-a356-37ba2af30d77?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "pzn": null,
  "route": "Oral Use",
  "source": "ema_art57_de",
  "ma_number": null,
  "substance": "Ferrous (Ii) Glycine Sulfate Complex",
  "atc_from_source": null,
  "authorisation_country": "Germany"
}

See everything about ferrous (ii) glycine sulfate complex.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.